GSK lowers vaccine sales forecast on weak demand for RSV jab Arexvy
UK pharma group’s shares fall 3% as third-quarter revenues miss expectations
Full Article
GSK lowers vaccine sales forecast on weak demand for RSV jab Arexvy
FT.com
0 shares
1 views